Developing Novel Genomic Risk Stratification Models in Soft Tissue and Uterine Leiomyosarcoma

CONCLUSIONS: Compared to traditional clinicopathologic models, genomic risk stratification demonstrates superior prediction of clinical outcome in STLMS and is comparable in ULMS.PMID:38488807 | DOI:10.1158/1078-0432.CCR-24-0148
Source: Clinical Cancer Research - Category: Cancer & Oncology Authors: Source Type: research